Dr Katinka van de Ven is a Research Fellow as part of the Drug Policy Modelling Program (DPMP) at the Social Policy Research Centre (SPRC), the University of New South Wales (UNSW). Her current work, on project Horizons, is focussed on how funding arrangements, purchasing mechanisms and workforce characteristics of alcohol and other drug (AOD) treatment agencies impacts on client outcomes. Katinka also specialises in the use and supply of performance and image enhancing drugs (PIEDs). She regularly acts as a consultant regarding PIED policy for various government bodies such as the Health Care Inspectorate in the Netherlands and the Advisory Council on the Misuse of Drugs in the UK, and provides PIED workshops to healthcare professionals in various countries.
Katinka is a Honorary Research Fellow at the Public Health Institute, Liverpool John Moores University. She is a Associate Editor of Performance Enhancement & Health and the Director of the Human Enhancement Drug Network (HEDN) (www.humanenhancementdrugs.com). The aim of HEDN is to provide evidence-based information, to share knowledge and experience, to provide harm reduction and human enhancement drug (HED) education, and to collaborate in this growing field of HEDs.